Home > Insider Trading > Filing (0001708138-20-000034)

Filing Details

Accession Number:: 0001708138-20-000034
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-04-15 16:17:00
Reporting Period:: 2020-04-13

Accepted Time:: 2020-04-15 16:17:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc.	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1226689	Neil Stahl	777 Old Saw Mill River Road Tarrytown NY 10591	Evp Research And Development	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-04-13	13,079	$52.03	24,459	No	4	M	Direct
Common Stock	Disposition	2020-04-13	7,582	$511.56	16,877	No	4	F	Direct
Common Stock	Disposition	2020-04-14	2	$517.99	16,875	No	4	S	Direct
Common Stock	Disposition	2020-04-14	267	$518.54	16,608	No	4	S	Direct
Common Stock	Disposition	2020-04-14	422	$519.85	16,186	No	4	S	Direct
Common Stock	Disposition	2020-04-14	2,096	$520.43	14,090	No	4	S	Direct
Common Stock	Disposition	2020-04-14	1,595	$521.32	12,495	No	4	S	Direct
Common Stock	Disposition	2020-04-14	758	$522.37	11,737	No	4	S	Direct
Common Stock	Disposition	2020-04-14	357	$524.26	11,380	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-04-13	13,079	$0.00	13,079	$52.03

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
25,000		2021-12-16	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,736	Indirect	By 401(k) Plan
Common Stock	7,831	Indirect	by 2018 GRAT
Common Stock	13,700	Indirect	by 2019 GRAT

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 267 shares of Company stock on April 14, 2020 at prices ranging from $518.14 to $518.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 14, 2020 at each separate price.
Represents volume-weighted average price of sales of 422 shares of Company stock on April 14, 2020 at prices ranging from $519.27 to $519.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 14, 2020 at each separate price.
Represents volume-weighted average price of sales of 2,096 shares of Company stock on April 14, 2020 at prices ranging from $520.01 to $520.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 14, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,595 shares of Company stock on April 14, 2020 at prices ranging from $521.01 to $521.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 14, 2020 at each separate price.
Represents volume-weighted average price of sales of 758 shares of Company stock on April 14, 2020 at prices ranging from $522.00 to $522.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 14, 2020 at each separate price.
Represents volume-weighted average price of sales of 357 shares of Company stock on April 14, 2020 at prices ranging from $524.00 to $524.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 14, 2020 at each separate price.
With respect to 75,000 underlying shares (of which 25,000 remain outstanding) the option became exercisable on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014. With respect to 48,079 underlying shares (of which 0 remain outstanding), the stock option award vested in four equal annual installments, commencing one year after the date of grant.